Steve Gavel, Chief Commercial Officer at Cabaletta Bio, Inc. (CABA), bought 22,170 shares at $2.27 ($50K) on 2026-01-21, disclosed to the SEC on 2026-01-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.